JUMP TO CONTENT
Ovarian cancer knot

Standing Strong on Ovarian Cancer Day

Posting date: 08/05/2025
Author: Inside ICON

Standing Strong on Ovarian Cancer Day:    ICON's Commitment to Advancing Care

Ovarian cancer remains one of the most challenging gynaecologic malignancies, both in terms of detection and treatment. Globally, it is the eighth most common cancer in women, with nearly 350,000 new cases reported each year. Despite progress in oncology, survival outcomes remain tightly linked to the timing of diagnosis.

In this article, Martin Lachs, Vice President, Oncology Project Management at ICON, shares his thoughts and insight into ICON’s commitment to supporting innovation, global collaboration, and improved outcomes for women around the world

A Disease Often Detected Too Late

The stark reality of ovarian cancer is its silent progression. Symptoms like bloating, abdominal discomfort, and changes in appetite are vague and often attributed to less serious conditions. As a result, only about 20% of ovarian cancer cases are detected at an early stage. This delay in diagnosis has profound consequences: five-year survival rates can range from as high as 93% when caught early to just 31% when detected late.

This challenge underscores the need for both public awareness and research into better diagnostic tools. Biomarkers, imaging technology, and AI-driven screening methods are all areas of active investigation, but no standard screening method has yet been established for the general population. The lack of early detection tools remains one of the key barriers to improved survival rates.

Hope on the Horizon

Fortunately, treatment options for ovarian cancer have expanded significantly in recent years. One of the most impactful developments has been the introduction of PARP inhibitors, which target cancer cells with BRCA mutations by interfering with their DNA repair mechanisms. Drugs such as olaparib and niraparib have brought real progress for patients with certain genetic profiles.

Martin noted, "Recent treatment advances have included PARP inhibitors, but there are many development programs looking at PD-1 inhibitor combinations and some Antibody Drug Conjugates (ADCs). One of our customers is particularly focused on immunotherapies and ADCs, so we are very excited to be part of their development program." Beyond PARP inhibitors, there is growing interest in immunotherapy and Antibody Drug Conjugates (ADCs). PD-1 and PD-L1 inhibitors, which help restore the immune system's ability to recognize and attack cancer cells, are currently being explored in combination with chemotherapy or targeted agents. 

Although early trials have shown mixed results, researchers are refining patient selection and combination strategies to unlock their full potential. ADCs, on the other hand, offer a highly targeted approach by linking a potent anti-cancer drug to an antibody that seeks out cancer cells. These "smart bombs" promise to deliver powerful effects with fewer side effects, and several ADCs are currently in development for ovarian and other gynaecologic cancers.

ICON's Role in Advancing Research

At ICON, we are proud to contribute meaningfully to this evolving landscape. We are currently supporting development programs focused on immunotherapies and ADCs, working closely with leading biopharmaceutical sponsors. Our experience in oncology clinical trials—particularly in gynaecologic cancers—positions us as a key partner in the global fight against ovarian cancer. Martin emphasized, "ICON is highly engaged with the global Investigator community in gynaecologic/ovarian oncology research. We have made important contributions to 13 ovarian cancer studies where many patients from North America & EMEA have participated in our ovarian cancer trials." Collaborating with the World's Leading Cooperative Groups A cornerstone of our success is our close collaboration with respected research networks such as ENGOT (European Network for Gynaecological Oncological Trials) and GOG (Gynaecologic Oncology Group). These organizations are instrumental in running high-quality clinical trials and have been central to many of the advances in ovarian cancer care.

Martin shared, "ICON’s excellent delivery of ovarian cancer studies is strongly correlated with our engagement with co-operative groups, like ENGOT covering Spain, Italy, France, Czech Republic, UK, Israel or GOG covering USA and Canada. ICON is proud of our strong experience in engaging with these co-operative groups and the difference we are trying to bring to the lives of patients and their families."

ENGOT brings together trial groups from multiple countries including Spain, Italy, France, the Czech Republic, the UK, and Israel, while GOG covers sites across the USA and Canada. Our long-standing partnerships with these groups help ensure that studies are executed efficiently and ethically, while staying deeply connected to local investigators and patients.

By aligning with ENGOT and GOG, ICON facilitates research that is both global in scope and locally relevant. We are able to leverage these networks to streamline patient recruitment, support investigator engagement, and uphold the highest standards in data quality and patient safety.

Why Our Work Matters

Every clinical trial represents more than data points. It represents a chance for a patient to access cutting-edge treatment, a family to find hope, and a community to move closer to a cure. At ICON, we never lose sight of the people behind the protocols. Our focus on collaboration, quality, and compassion drives our mission to improve patient outcomes.

We are especially proud of our efforts to foster inclusion in clinical trials, ensuring women from varied backgrounds and regions have access to potentially life-changing treatments. With every study we support, we strive to close the gap between medical research and the real-world needs of patients and caregivers.

Looking to the Future

The fight against ovarian cancer is far from over, but progress is being made every day. Through our partnerships, scientific expertise, and unwavering dedication, ICON continues to push boundaries and make a meaningful difference in women’s health.

This Ovarian Cancer Day, we honour the courage of patients, the dedication of researchers, and the power of collaboration. We remain steadfast in our commitment to helping bring forward the next generation of therapies that will transform lives.

Join Us in Making a Difference

Whether you are a clinician, researcher, or someone passionate about advancing healthcare, ICON offers opportunities to contribute to this important mission. Together, we can ensure that innovation reaches the women who need it most - faster, safer, and more effectively. 

View our current job openings at ICON today.

List #1

Related jobs at ICON

Contract Specialist

Salary

Location

Czech Republic, Prague

Location

Prague

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

Accounting & Finance

Job Type

Permanent

Description

We are currently seeking a Contract Specialist I to join our diverse and dynamic team. As a Contract Specialist I at ICON, you will play a pivotal role in facilitating the negotiation and management o

Reference

JR134366

Expiry date

01/01/0001

Tereza Svobodova Read more Shortlist Save this role
HR Advisor (Shared Service Operations)

Salary

Location

Poland, Warsaw

Department

Full Service - Corporate Support

Location

Sofia

Warsaw

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

HR Advisor

Job Type

Permanent

Description

The role:We are currently seeking an HR Advisor to join our diverse and dynamic team. As an HR Advisor at ICON, you will provide critical support across HR functions, offering guidance and expertise t

Reference

JR134275

Expiry date

01/01/0001

Maya Katsarska Read more Shortlist Save this role
PV Associate/Sr PV Associate

Salary

Location

India, Chennai

Location

Chennai

Remote Working

Office or Home

Business Area

ICON Full Service & Corporate Support

Job Categories

Drug Safety

Job Type

Permanent

Description

Roles & Responsibilities:Review and process safety events (pre-marketing, post-marketing, medical device and drug) and/or other medically related information per assigned tasks and project specific pr

Reference

JR127208

Expiry date

01/01/0001

Archana Bakkiyarajan Read more Shortlist Save this role
Senior Accounts Receivable Associate

Salary

Location

India, Chennai

Location

Chennai

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

Accounting & Finance

Job Type

Permanent

Description

We are currently seeking a Senior Accounts Receivable Associate to join our diverse and dynamic team. As a Senior Accounts Receivable Associate at ICON, you will play a crucial role in managing and op

Reference

JR133845

Expiry date

01/01/0001

Puja Jaiswal

Author

Puja Jaiswal
Read more Shortlist Save this role
View all
List #1

Related stories

female pharmacist selecting medicine
Careers in Pharmacovigilance: Opportunities in Patient Safety and Drug Development

Teaser label

Industry

Content type

Blogs

Publish date

08/25/2025

Summary

Careers in Pharmacovigilance Pharmacovigilance, also known as drug safety, is one of the most important pillars of modern medicine. It ensures that once a medicine is developed, tested, and appro

Teaser label

Learn the skills that open doors to a career in drug safety and development.

Read more
Headshot of female
Leadership in Mexico: Karen Hahn’s Journey at ICON

Teaser label

Our People

Content type

Blogs

Publish date

08/14/2025

Summary

A Leader’s Journey: Karen Hahn on Growth, Culture and the Future of ICON Mexico Karen Hahn’s career at ICON has unfolded over more than 15 years, shaped not by a rigid plan, but by openness to ch

Teaser label

Over 15 years, Karen Hahn has grown alongside ICON Mexico - from a team of 40 in 2010 to over 2,000 today.

Read more
Headshot of female
Building a Career at ICON: Susie's journey from HR Analyst to Senior VP

Teaser label

Inside ICON

Content type

Blogs

Publish date

08/07/2025

Summary

Building a Career at ICON: A Conversation with Susie McEvoy, Senior VP of HR At ICON, career journeys are rarely linear – and Susie McEvoy’s story is a powerful example of that. From joining as a

Teaser label

Discover how Susie built a successful career at ICON, progressing from HR Analyst to Senior Vice President.

Read more
View all
List #1

Recently viewed jobs

Medical Research Representative

Salary

Location

US, San Antonio, TX, IDS

Location

San Antonio

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

Facilities & Administratives Services

Clinic

Job Type

Temporary Employee

Description

Job Advert PostingWe are currently seeking a Dietary Aid to join our diverse and dynamic team. As a Custodian at ICON, you will play a vital role in maintaining a clean and safe environment for our em

Reference

JR129307

Expiry date

06/12/2026

Stephanie Curran Read more Shortlist Save this role
View all
View Jobs

Browse popular job categories below or search all jobs above